OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
August 02, 2009
Individuals and companies at the top seem to have no problem short-circuiting their success.
Determined to prevent further supply-chain breaches, industry takes charge, offers proposals.
August 01, 2009
As the pharmaceutical supply chain expands, sponsor companies need to weigh all their options.
The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.
A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.
The author provides advice about evaluating contract analytical laboratories and establishing an effective procedure for working with them to perform reliable stability studies.
A Q&A with Pfizer CentreSource, moderated by Jim Miller.
Leading contract manufacturing organizations share their views on the current and future market dynamics shaping pharmaceutical outsourcing.
July 30, 2009
Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases final rule on authorized generic drugs and NDA submissions; more...
July 28, 2009
China's State Food and Drug Administration has completed a new draft of GMP guidelines, but after a series of quality-control events, it will take time for the country to regain the global pharmaceutical industry's trust.